Position in LNTH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$474,490
+$20,112 QoQ
Shares Held
4,277
-51.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#259
of 462 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AVIVA PLC holds $99,862,653 across 5 Drug Manufacturers - Specialty & Generic names. LNTH ranks #5 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,197,763 | $40,580,210 | |
| 2 | ZTS |
Zoetis Inc.
|
389,051 | $27,957,204 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
32,903 | $17,827,832 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
77,269 | $13,022,917 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
This page
|
4,277 | $474,490 |
All Filings in LNTH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $474,490 | 4,277 | Shares | Defined | 2026-08-13 | |
| 2025-09-30 | $454,378 | 8,859 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $492,387 | 6,015 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $633,814 | 6,494 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $635,613 | 7,105 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $665,963 | 6,068 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $607,634 | 7,568 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $622,897 | 10,008 | Shares | Defined | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||